Related Experiment Video
Updated: May 16, 2025

04:05
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.7K
Comprehensive Analysis of Heart Failure Subtypes Presenting at Emergency Department for Acute Heart Failure
Journal of Emergency Nursing
|March 31, 2025
Summary
Heart failure subtypes have unique clinical and biomarker profiles. Recognizing these differences in the emergency department can improve patient risk stratification and treatment outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
- Biomarkers
Background:
- Pathophysiological complexities across heart failure categories (reduced, midrange, preserved ejection fraction) remain incompletely understood despite advances in diagnostics.
- This study focuses on characterizing patients presenting with acute heart failure to the emergency department across these three subtypes.
Purpose of the Study:
- To analyze and compare the distinct clinical characteristics, echocardiographic measures, and biomarker profiles of patients across different heart failure subtypes.
- To identify potential differences that can inform risk stratification and tailored interventions in the emergency department setting.
Main Methods:
- Retrospective analysis of 954 acute heart failure patients (2016-2023) utilizing electronic health records.
- Data collection included triage, emergency department, and hospitalization information.
- Kaplan-Meier survival analysis and an elastic net model were employed for statistical analysis.
Main Results:
- Patients with heart failure with preserved ejection fraction were older (median 80 years) compared to other subtypes.
- Heart failure with reduced ejection fraction patients exhibited higher prevalence of cardiomegaly, pleural effusion, orthopnea, and elevated NT-proBNP.
- Prediction models demonstrated strong performance: 0.84 AUC in-hospital and 0.80 AUC for 30-day predictions.
Conclusions:
- Distinct clinical and biomarker profiles exist among heart failure subtypes.
- Emergency nurses' recognition of these differences can enhance risk stratification and guide tailored interventions, improving patient outcomes.
- Integrating subtype-specific data into emergency department protocols can optimize care, especially during prolonged patient boarding.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: β-Blockers
284
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
284
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Imaging Studies for Cardiovascular System II:Types of Echocardiography
211
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
211
Heart Failure Drugs: Inotropic Agents
445
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
445

